Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
Nature Careers | Northern British Columbia Fort Nelson, British Columbia | Canada | about 11 hours ago
pipelines, proficiency in genomic association analyses, particularly involving large-scale datasets, and familiarity with cloud computing and/or high-performance computing (HPC) environments
-
. degree or equivalent in Telecommunications and Computer Science. Experience: The ideal candidate should have proven experience (in terms of high-ranking journals or international conference proceedings and
-
of high-performance computing environments on Linux servers, and knows how to submit batch-run jobs. • Experienced in processing and analyzing bulk/single-cell genomic data or spatial omics data or image
-
characterization of various gastrointestinal cancers (GI), including colorectal, pancreatic, gastric, esophageal, and hepatocellular cancers. Our group performs cutting-edge research in GI oncology, is very
-
is a pan cancer national research autopsy programme in which post-mortem sampling allows access to tissue from all sites of metastasis, and to date has recruited over 390 patients and performed over
-
, and access to leading high-performance computing facilities. • The valuable opportunity to join a cohort of innovative scholars collectively shaping the future of AI, through the cross
-
discoveries into precision oncology. State-of the Art Resources – The Princess Margaret Cancer Centre provides high-performance computing, single-cell sequencing, and advanced AI platforms. A Prime Research Hub
-
staff, data storage and computer processing power. TRACERx has been highly successful, as of 2023 sequencing data from more than 400 patients have been fully analysed resulting in a flow of high-impact
-
and other emerging single cell platforms. Proficiency in R and at least one relevant programming language (e.g. Python/Perl) and experience working on a high-performance computing cluster in a linux
-
shape the future we envision. Summary Postdoc position is available in the laboratory of Dr. Dorina Avram in the Department of Immunology and Immuno-Oncology Program at the Moffitt Cancer Center to study